• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Are we prescribing antibiotics wrong?

Are we prescribing antibiotics wrong?

The message has always been clear: make sure to finish your full course of antibiotics. Or else? Risk the development of antibiotic resistance - a...
Outsourcing Clinical Trials Outside of the US

Outsourcing Clinical Trials Outside of the US

Outsourcing clinical trials has been a subject of both controversy and relevance in the pharmaceutical community. It is an important part of drug...
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Last year was a banner year for new drugs, with 46 new molecular entities approved by the FDA, compared to 22 in 2016. 2017 also saw the approval of...
Two-dimensional liquid chromatography with multiple heart-cutting

Two-dimensional liquid chromatography with multiple heart-cutting

Two-dimensional liquid chromatography (2D-LC) has obtained increasing focus over the past two decades. At LEO Pharma, we continuously evaluate new...
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Applying validation standards to bio/pharmaceutical logistics, the science of transporting bio/analytical, clinical and manufactured product, is an...
Are we prescribing antibiotics wrong?
Are we prescribing antibiotics wrong?
Outsourcing Clinical Trials Outside of the US
Outsourcing Clinical Trials Outside of the US
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
Two-dimensional liquid chromatography with multiple heart-cutting
Two-dimensional liquid chromatography with multiple heart-cutting
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Latest White Papers

  • Random

Latest News

  • Title
  • Most Views
  • Recently Added
  • Ordering
  • Random
Load More
Load More
MOBILion Systems HRIM

MOBILion Systems Inc. has launched of its first commercial High-Resolution Ion Mobility (HRIM) ...

Clinical Trial Data at AACR

Immunicom, Inc., a global biotech company that is redefining immuno-oncology with breakthrough ...

Phillips-Medisize Aria Smart Autoinjector

Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, ...

Merck's new synthetic cholesterol product

To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck, ...

Load More
Load More
Load More

Latest Updates

Blueprint Medicines Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT™ (avapritinib) for the treatment of adult patients with advanced systemic ...

Blueprint Medicines Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT™ (avapritinib) for the treatment of adult patients with advanced systemic mastocytosis (Advanced SM)...

Blueprint Medicines Corporation today announced that the U.S. Food and ...

Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the virtual 2021 American Society of Clinical Oncology ...

Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the virtual 2021 American Society of Clinical Oncology (ASCO®) Annual Meeting held June 4-8.

Labcorp’s oncology platform brings together the company’s ...

OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides ...

OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears.

It is a complete solution consisting of OptraSCAN's digital pathology scanner, ...

BurstIQ, the leading provider of blockchain-based data exchange solutions, announced today that the company has entered into a research collaboration agreement with The National Center for Advancing ...

BurstIQ, the leading provider of blockchain-based data exchange solutions, announced today that the company has entered into a research collaboration agreement with The National Center for Advancing Translational Sciences (NCATS).

At the National Institutes of Health (NIH) to address the ...

CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the Nasdaq.

Global Market®  under the Company's ...

CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the Nasdaq.

Global Market®  under the Company's current ticker symbol "CLGN" and will begin trading at the open of market on June 4, 2021. At such time, ...

Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent for ZICOH®.

Designed to better facilitate patient-provider interactions and ...

Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent for ZICOH®.

Designed to better facilitate patient-provider interactions and play a role in reducing prescription opioid abuse, the ZICOH® device and its software are designed to ...

We use cookies to ensure you get the best experience on this website Privacy Policy